Articles

340B is a discount program for low-income areas that increases resources and allows for patient expansion. In this session, panelists discuss the accuracy of pricing, the current state of the program, and future developments.

In this session, industry leaders discuss defining clinical utility for genomic testing and make recommendations to ensure appropriate implementation in cancer care.

Technology can enhance the patient engagement experience, creating a willingness among patients to receive advice and counseling virtually. In this session, experts discuss the challenges of engaging patients and the future of technology in the healthcare system as it relates to cancer care.

No one truly knows what it is like to navigate cancer until they are diagnosed with the disease. In this session, survivors shared their stories and messages of hope as we prepare for Thanksgiving.

Depending on the stakeholder’s point of view, value-based contracting can have many definitions and meanings. In this session, experts from across the healthcare continuum explore what is working, what has failed, and what lessons have been learned regarding value-based contracting.

Designing and implementing value-based contracts is a challenge to stakeholders across the cancer care ecosystem. In this discussion, panelists analyze the future of these contracts and precision medicine.

During the COVID-19 pandemic, telehealth has been considered a silver lining in that it has allowed increased access to care. In this session, experts discuss the early challenges of telehealth and how it can improve the future of cancer care.

The COVID-19 pandemic has had many devastating effects beyond the spread of the disease, and these effects have led to important lessons in the healthcare system. In this session, experts discuss key takeaways from the pandemic and the future of cancer care in the new normal.

The COVID-19 pandemic has allowed telemedicine to be widely adopted for the delivery of cancer care. In this session, experts discuss some of the benefits of this technology, as well as key legal issues that need to be addressed.

Value-based contracts (VBCs) are the future of healthcare. However, many barriers to entry exist for the exploration of these contracts. In this discussion, experts offer legal perspectives on the goals of VBCs and potential hurdles and solutions.